Annotated Medicine and Device Lists


Dapsone

This medicine is present in:

List Section Observation
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 03.02. ANTIBACTERIANOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.4. Antileprosy medicines No observations
PAHO Strategic Fund Medicine List 2.2. Antileprosy med. No observations
Peru 6.2.3 Anti-Leprosy No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 04 ANTIMICOBACTERIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
Guyana. Essential Medicines List. 2020-2021 7.03. Antileprosy Medicines No observations
Suriname. NGK-C-011 6.05 Anti-Leprosy drugs No observations
Haiti. National List of Essential Medicines 06.02.03 Antileprosy No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.4. Antileprosy medicines No observations
PAHO Strategic Fund Medicine List 2.2. Antileprosy med. No observations
Peru 6.2.3 Anti-Leprosy No observations
Ecuador Essential Medicines List - Ecuador No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Infectives Antileprotic Others observations:
Retard
Costa Rica. Caja Costarricense de Seguro Social. 2019 02. Antibióticos No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 04 ANTIMICOBACTERIAS No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 30 TABLETAS
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.02 ANTILEPROTIC DRUGS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 04. ANTIMICOBACTERIAS (TUBERCULOSIS Y LEPRA) No observations
El Salvador - 2019 ANTIMICOBACTERIANOS No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.02. ANTIBACTERIANOS No observations
Guyana. Essential Medicines List. 2020-2021 7.03. Antileprosy Medicines No observations
Guyana. Essential Medicines List. 2020-2021 7.09.02.04. Anti-pneumocystosis and antitoxoplasmosis Medicines No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 8:38 Anti-leprotic agents No observations
Suriname. NGK-C-011 6.05 Anti-Leprosy drugs No observations
Haiti. National List of Essential Medicines 06.02.03 Antileprosy No observations
Barbados. Barbados National Drug Formulary (BNDF) 08.16.92 Miscellaneous Antimycobacterials No observations
Bahamas. Drug Formulary 07.01.04. Antileprotics No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.4. Antileprosy medicines No observations
PAHO Strategic Fund Medicine List 2.2. Antileprosy med. Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Haiti. National List of Essential Medicines 06.02.03 Antileprosy No observations

Information Resources: Dapsone

Loading ...
Loading ...
Loading ...
No information available